{
    "2019-06-04": [
        [
            {
                "time": "2018-05-17",
                "original_text": "FDA approves Lilly's migraine drug as first ever cluster headache treatment",
                "features": {
                    "keywords": [
                        "FDA",
                        "approves",
                        "Lilly",
                        "migraine",
                        "drug",
                        "cluster",
                        "headache",
                        "treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-04",
                "original_text": "Notable ETF Inflow Detected - VV, ACN, NKE, LLY",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "VV",
                        "ACN",
                        "NKE",
                        "LLY"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-03",
                "original_text": "Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down",
                "features": {
                    "keywords": [
                        "Celldex",
                        "Presents",
                        "Data",
                        "CDX-3379",
                        "ASCO",
                        "Stock",
                        "Down"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-29",
                "original_text": "3 Cancer Stocks Given a Lift by Amgen",
                "features": {
                    "keywords": [
                        "Cancer",
                        "Stocks",
                        "Amgen",
                        "Lift"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes",
                "features": {
                    "keywords": [
                        "FDA",
                        "Accepts",
                        "New",
                        "Drug",
                        "Application",
                        "Triple",
                        "Combination",
                        "Tablet",
                        "Type",
                        "2",
                        "Diabetes"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}